Issue

  • Issue Number: 
    5 Sept/Oct

    The First International CLI Summit on Lower Extremity PVD and Critical Limb Ischemia
    A Pre New Cardiovascular Horizons Event
    October 26-27, 2005, New Orleans Marriott, New Orleans, Louisiana
    www.clisummit.com

    New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing
    October 27-29, 2005, New Orleans Marriott, New Orleans, Louisiana
    www.newcvhorizons.com

    Can you tell us about the history and philosophy behind the New Cardiovascular Horizons meeting?
    New Cardiovascular Horizons (NCVH) began in 2000 as a small, local, multi-dis

  • Issue Number: 
    5 Sept/Oct

    When offered the position of Editor-in-Chief at VDM, I was told that I would have a great deal of freedom to generate my imprint on this publication, and a few privileges; perhaps a little glamour as well. I was also given the “power” to over-rule (if necessary) manuscript reviewers and make some decisions of my own — provided they were rational and based on compelling reasons. Well, I finally found something worthy of such a stance!

    The article by Baerlocher, et al. on uterine artery embolization was submitted to VDM and put through the usual peer-review process. The assigned revie

  • Issue Number: 
    5 Sept/Oct

    Introduction
    True aneurysms of the extracranial internal carotid artery (EICA) are extremely rare and have been thought to be secondary to atherosclerosis.1 Other less common causes include fibromuscular dysplasia, Takayasu’s Arteritis, neurofibromatosis and Marfan’s syndrome.2,3 In addition, pseudoaneurysms may arise after trauma, carotid surgery, infection and radiation. Rupture is rare with this form of aneurysm, however, neurological symptoms are relatively common and conservative therapies carry significant risk.

    Case Report
    A 39-year-old n

  • Issue Number: 
    5 Sept/Oct

    Introduction
    Early stent-graft designs were ill-prepared to face the hemodynamic forces generated by aortic blood flow and pressure. Long-term results were marred by high rates of migration,1 component separation,2 and structural failure.3 Current designs have proven to be more stable.2 Though more rigorous pre-clinical testing has helped to assess the likelihood of each known failure mode before devices are implanted in patients, there is still no consensus as to the test conditions, because the hemodynamic environment of the endovascular s

  • Issue Number: 
    5 Sept/Oct

    Abstract
    Purpose.
    Peripheral arterial disease (PAD), defined as the presence of atherosclerotic occlusive vascular disease of the extremities, is a marker of systemic atherosclerosis, and has emerged as a strong risk factor for cardiovascular morbidity and mortality. Early diagnosis and aggressive medical therapy can significantly reduce cardiovascular risk profiles in such patients.

  • Issue Number: 
    5 Sept/Oct

    Introduction
    Vascular injury following trauma is seen almost daily in our profession, The bleeding must be stopped as early as possible and this task is usually managed by surgeons. However, there are conditions where the surgical approach involves high risk and is less practical than a swiftly performed endovascular procedure. This may depend on the site, as well as the vessel affected in the process of injury, resulting in leakage that causes blood loss with or without the formation of a pseudoaneurysm.

    Angiographic diagnosis followed by transcatheter sealing of the site of leak

  • Issue Number: 
    5 Sept/Oct

    Abstract
    Background.
    Non-atherosclerotic internal carotid artery (ICA) lesions are uncommon. The incidence of ICA dissections is estimated to be 2.5 to 3 per 100,000, with a 10% annual recurrence rate of thromboembolic. The incidence of fibromuscular dysplasia (FMD), the most common non-traumatic, non-atherosclerotic, non-inflammatory lesion of the ICA is estimated to be 0.02%, with a more benign natural history. For both pathologies, antithrombotic therapy and blood pressure control are initial therapeutic modalities, surgery only being indicated after ischemic events or aneurysmal d

  • Issue Number: 
    5 Sept/Oct

    Introduction
    The accepted standard of care for patients with venous thromboembolism (VTE) is anticoagulant therapy. Inferior vena caval (IVC) filters are reserved for those patients who fail anticoagulant therapy, or have a complication or contraindication to anticoagulant therapy.1 Until the early 1970’s, the only method of IVC interruption was surgical, either by clipping, ligation or plication. The first clinical experience of an endoluminally-placed device to interrupt IVC flow was reported by Mobin-Uddin et al. in 1969.2 However, it was not until the intro

  • Issue Number: 
    5 Sept/Oct

    The ebb and flow of medical advancement
    The field of vascular intervention, particularly percutaneous, is a rapidly expanding field. With a decrease in complication and readmission rates and procedural costs coupled with an increase in success and patient satisfaction rates, the number of treatments offered and the variety of diseases targeted is growing at a quickening pace. The increasing complexity of the field is reflected by its multidisciplinary nature (one need not look further than the inspiration behind Vascular Disease Management). Relatively new procedures rapidly replace tr

  • Issue Number: 
    5 Sept/Oct

    Introduction
    The emergence of vascular surgery as a multidisciplinary specialty in its own regard has allowed significant advances in the diagnosis, medical management and operative techniques applied to patients with peripheral occlusive and aneurysmal vascular disease. However, its increasing effectiveness in the treatment of circulatory disorders continues to be tempered by the fact that functional status and longevity after successful intervention are often determined by coronary co-morbidity.1 Indeed, the inherent cardiac stress induced by surgery may provoke ischemic


Digital Supplements

Using Advanced Technology to
Treat Occluded Below-the-Knee Arteries


This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.


Superior Mesenteric Artery Revascularization and
Retrograde Visualization


This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.

CME Showcase

"Diabetic Peripheral Neuropathy"

Upcoming Accredited Webcast

Release Date: December 22, 2008

Expiration Date: December 22, 2009

This activity is supported by an educational grant from PamLabs.
This activity is sponsored by the North American Center For Continuing Medical Education (NACCME).

To register for this Webcast, visit www.naccme.com/program/n-558/



LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI

Live Symposium

Date: February 26-28
Location: Loews Miami Beach Hotel
Miami Beach, Florida 33139
Phone: (305) 604-1601
Toll Free: 1-877-563-9762

This activity is sponsored by the North American Center for Continuing Medical Education.

CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence


A Complimentary CME Accredited Lunch Symposium

Date: Friday, September 12, 2008
12:00 pm - 1:15 pm
Location: Hynes Convention Center
900 Boylston Street, Room 304
Boston, MA 02115

This activity is supported by an educational grant from Bracco Diagnostics Inc.


REVIEW OUR OTHER
CARDIOLOGY BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • CathLab Digest
  • Journal of Invasive Cardiology
  • EP Lab Digest
  • Cath Lab Basics